FIBROBIOLOGICS INC. - COMMON STOCK

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

06 6 2024 09:31:00 提供 Nasdaq GlobeNewswire

FibroBiologics Announces 2024 Annual Meeting of Stockholders

15 5 2024 16:30:00 提供 Nasdaq GlobeNewswire

FibroBiologics Files 2024 First Quarter Report

14 5 2024 17:24:58 提供 Nasdaq GlobeNewswire

FibroBiologics to Present at the BIO International Convention 2024

07 5 2024 09:31:00 提供 Nasdaq GlobeNewswire

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

25 4 2024 08:00:00 提供 Nasdaq GlobeNewswire

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

11 4 2024 09:31:00 提供 Nasdaq GlobeNewswire

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

04 4 2024 09:31:00 提供 Nasdaq GlobeNewswire

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

28 3 2024 09:31:00 提供 Nasdaq GlobeNewswire